Metraipolis › archive › dc_679a0bbcabaa
Baseline Neuropsychological Characteristics of Adolescents and Young Adults with Down Syndrome Who Participated in Two Clinical Trials of the Drug Memantine — Europe PMC PMID:41300171
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41300171
- DOI
- 10.3390/brainsci15111164
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T23:42:04.364Z
- SHA-256 of the archived text
2e2629beeba710f10da4748cfd3044b2d9fa95d681640d0300704ef76f086689- Stable URL of this page
https://metraipolis.com/documento/dc_679a0bbcabaa
How to cite
Baseline Neuropsychological Characteristics of Adolescents and Young Adults with Down Syndrome Who Participated in Two Clinical Trials of the Drug Memantine — Europe PMC PMID:41300171 — Europe PMC (en), https://europepmc.org/article/MED/41300171 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_679a0bbcabaa (Metraipolis archive dc_679a0bbcabaa, sha256 2e2629beeba710f10da4748cfd3044b2d9fa95d681640d0300704ef76f086689)
BibTeX
@misc{dc679a0bbcabaa,
title = {Baseline Neuropsychological Characteristics of Adolescents and Young Adults with Down Syndrome Who Participated in Two Clinical Trials of the Drug Memantine — Europe PMC PMID:41300171},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41300171},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_679a0bbcabaa; sha256 2e2629beeba710f10da4748cfd3044b2d9fa95d681640d0300704ef76f086689},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41300171. Agents can read the archived copy with the MCP tool read_document.